Entheon Biomedical (XCNQ:ENBI) EV-to-FCF : -2.57 (As of May. 05, 2024)

Entheon Biomedical EV-to-FCF Chart

Entheon Biomedical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
EV-to-FCF	Get a 7-Day Free Trial															-0.56	-1.36	-12.75	-2.66	-0.68

Competitive Comparison of Entheon Biomedical's EV-to-FCF

For the Biotechnology subindustry, Entheon Biomedical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's EV-to-FCF falls into.

Entheon Biomedical EV-to-FCF Calculation

Entheon Biomedical's EV-to-FCF for today is calculated as:

Entheon Biomedical's current Enterprise Value is C$0.93 Mil.
Entheon Biomedical's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical  (XCNQ:ENBI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Entheon Biomedical's PE Ratio for today is calculated as:

Entheon Biomedical's share price for today is C$0.215.
Entheon Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Entheon Biomedical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description